Specify a stock or a cryptocurrency in the search bar to get a summary
Integrum AB Series B
6Y1Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was founded in 1962 and is headquartered in Mölndal, Sweden. Address: Gemenskapens gata 9, Mölndal, Sweden, 431 53
Analytics
WallStreet Target Price
813.86 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 6Y1
Dividend Analytics 6Y1
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 6Y1
Stock Valuation 6Y1
Financials 6Y1
Results | 2019 | Dynamics |